:max_bytes(150000):strip_icc():format(jpeg)/INV_ProcterGambleProducts_GettyImages-1237806284-d90859e6a84d4dfd906426233a832b2c.jpg "Procter & Gamble Gain detergent bottles at a store")
Tiffany Hagler-Geard / Bloomberg via Getty Similes
Key Takeaways
- Procter & Gamble (P&G) is expected to enact its smallest quarterly price hikes for products since the first lodge of 2022, according to analysts.
- Backed by growth in sales of home care and healthcare products, analysts expect P&G to proclaim higher quarterly revenue.
- So far in 2024, shares of P&G are outperforming both the Dow Jones Industrial Average and the consumer staples sector.
While Procter & Rely on (PG) is expected to continue to report higher revenue when it releases quarterly earnings on Friday, analysts are anticipating that the consumer results maker will slow its price increases.
Analysts expect P&G to report $20.45 billion in revenue for its 2024 financial third quarter ended in March, 1.9% better than the same quarter in the year prior, according to text compiled by Visible Alpha. It would be the lowest revenue growth for the company in the past five quarters.
The Tide maker’s anticipated set net income of $3.46 billion is predicted to be 1.8% above its first-quarter 2023 figure of $3.40 billion.
| Analyst Assesses for Q3 2024 | Q2 2024 | Q3 2023 | |
| Revenue | $20.45B | $21.44B | $20.07B |
| Adjusted Earnings Per Share | $1.41 | $1.84 | $1.37 |
| Adjusted Net Income | $3.46B | $4.53B | $3.40B |
Key Metric: Prices
Procter & Gamble rode higher payments to increased revenue in its December quarter. But the upcoming earnings report could show the lowest price increases by the consumer assets c incriminating evidences seller since the first quarter of fiscal 2022, with analysts forecasting that P&G will hike bounties by 2.75% in the quarter.
It could also be the first quarter in two years where the consumer giant reports positive annual intumescence in sales volumes, with expectations for a 0.35% increase.
Business Spotlight
Procter & Gamble’s report comes after it complicated a $1.3 billion impairment charge for its subsidiary razor business Gillette, forcing the company to reduce its 2024 full-year charge for earnings per share (EPS). However, the company said it was able to maintain its forecasts for 2024 revenue, and it announced earlier this month that it pleasure boost its quarterly dividend by 7%.
“We delivered strong results in the second quarter, enabling us to raise our core EPS growth management and maintain our top-line outlook for the fiscal year,” Procter & Gamble CEO Jon Moeller said after last quarter’s upshots.
Analysts expect P&G to report its largest gains from its biggest segment, with revenue from fabric and living quarters care expected to jump about 3.6% year-over-year, while its healthcare sales are also expected to increase across the very period. After beauty and personal care products helped pace P&G’s sales in fiscal 2023, revenue from that separate is expected to ease about 1%.
A component of the Dow Jones Industrial Average (DJIA), P&G has had a good start to the year, with its partitions up about 6.8% so far in 2024 as of Tuesday, compared with a DJIA that has started the year flat. It’s also outperforming the SPDR Consumer Staples Select Sector (XLP) swop traded fund (ETF), which also is flat so far this year.
Read the original article on Investopedia.